ERBB2 and breast carcinoma: In another study, BT474 and SKBR3 HER2+ breast cancer cell lines were cultured with constant increasing doses of T-DM1 (from IC25 to 4 μg/mL in BT474 and 0.05 μg/mL in SKBR3) over a 9-month period [39].